Jeffrey M Lackner - Publications

Affiliations: 
University at Buffalo Jacobs School of Medicine and Biomedical Sciences 
Area:
chronic pain; outcome research; comorbidities, anxiety, worry, problem solving

35 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Roger AH, Gudleski GD, Quigley BM, Zvolensky MJ, Lackner JM. Pain Catastrophizing and Clinical Outcomes Among Patients Receiving a Novel Cognitive-Behavioral Therapy for Irritable Bowel Syndrome: An Experimental Therapeutics Approach. Behavior Therapy. 54: 623-636. PMID 37330253 DOI: 10.1016/j.beth.2023.01.004  0.708
2022 Lackner JM, Jaccard J, Quigley BM, Ablove TS, Danforth TL, Firth RS, Gudleski GD, Krasner SS, Radziwon CD, Vargovich AM, Clemens JQ, Naliboff BD. Study protocol and methods for Easing Pelvic Pain Interventions Clinical Research Program (EPPIC): a randomized clinical trial of brief, low-intensity, transdiagnostic cognitive behavioral therapy vs education/support for urologic chronic pelvic pain syndrome (UCPPS). Trials. 23: 651. PMID 35964133 DOI: 10.1186/s13063-022-06554-9  0.692
2022 Lackner JM, Gudleski GD, Radziwon CD, Krasner SS, Firth RS, Naliboff BD, Vargovich AM, Borden AB, Mayer EA. Cognitive flexibility improves in cognitive behavioral therapy for irritable bowel syndrome but not nonspecific education/support. Behaviour Research and Therapy. 154: 104033. PMID 35653934 DOI: 10.1016/j.brat.2022.104033  0.72
2022 Radziwon CD, Quigley BM, Vargovich AM, Krasner SS, Gudleski GD, Mason SR, Borden AB, Lackner JM. Do I really have to do my homework? The role of homework compliance in cognitive behavioral therapy for irritable bowel syndrome. Behaviour Research and Therapy. 152: 104063. PMID 35248876 DOI: 10.1016/j.brat.2022.104063  0.705
2021 Jacobs JP, Gupta A, Bhatt RR, Brawer J, Gao K, Tillisch K, Lagishetty V, Firth R, Gudleski GD, Ellingson BM, Labus JS, Naliboff BD, Lackner JM, Mayer EA. Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome. 9: 236. PMID 34847963 DOI: 10.1186/s40168-021-01188-6  0.672
2021 Lackner JM, Jaccard J. Specific and common mediators of gastrointestinal symptom improvement in patients undergoing education/support vs. cognitive behavioral therapy for irritable bowel syndrome. Journal of Consulting and Clinical Psychology. 89: 435-453. PMID 34124927 DOI: 10.1037/ccp0000648  0.477
2021 Dunlap LJ, Jaccard J, Lackner JM. Minimal-Contact Versus Standard Cognitive Behavioral Therapy for with Irritable Bowel Syndrome: Cost-Effectiveness Results of a Multisite Trial. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. PMID 33821928 DOI: 10.1093/abm/kaaa119  0.358
2020 Lackner JM, Quigley BM, Radziwon CD, Vargovich AM. IBS Patients' Treatment Expectancy and Motivation Impacts Quality of the Therapeutic Alliance With Provider: Results of the IBS Outcome Study. Journal of Clinical Gastroenterology. PMID 32301832 DOI: 10.1097/MCG.0000000000001343  0.303
2019 Smith R, Gudleski GD, Lane RD, Lackner JM. Higher Emotional Awareness Is Associated With Reduced Pain in Irritable Bowel Syndrome Patients: Preliminary Results. Psychological Reports. 33294119868778. PMID 31407944 DOI: 10.1177/0033294119868778  0.638
2019 Lackner JM, Jaccard J. Cognitive-behavioural therapy for IBS comes home: mapping a route for efficacy and efficiency in the digital age. Gut. PMID 31337642 DOI: 10.1136/Gutjnl-2019-318583  0.433
2018 Lackner JM, Jaccard J. Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 30613000 DOI: 10.1016/J.Cgh.2018.10.033  0.416
2018 Lackner JM, Jaccard J, Radziwon CD, Firth RS, Gudleski GD, Hamilton F, Katz LA, Keefer L, Krasner SS, Ma CX, Sitrin MD, Brenner DM. Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up. The American Journal of Gastroenterology. PMID 30429592 DOI: 10.1038/S41395-018-0396-X  0.696
2018 Lackner JM, Jaccard J, Keefer L, Brenner D, Firth R, Gudleski GD, Hamilton F, Katz LA, Krasner SS, Ma CX, Radziwon C, Sitrin MD. Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome. Gastroenterology. PMID 29702118 DOI: 10.1053/J.Gastro.2018.03.063  0.71
2017 Keller CE, Wilcox CM, Gudleski GD, Branham S, Lackner JM. Beyond Abdominal Pain: Pain Beliefs, Pain Affect, and Distress as Determinants of Quality of Life in Patients With Chronic Pancreatitis. Journal of Clinical Gastroenterology. PMID 28858939 DOI: 10.1097/Mcg.0000000000000922  0.614
2017 Fehnel SE, Ervin CM, Carson RT, Rigoni G, Lackner JM, Coons SJ. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 20: 618-626. PMID 28408004 DOI: 10.1016/j.jval.2016.11.001  0.393
2017 Gudleski GD, Satchidanand N, Dunlap LJ, Tahiliani V, Li X, Keefer L, Lackner JM. Predictors of medical and mental health care use in patients with irritable bowel syndrome in the United States. Behaviour Research and Therapy. 88: 65-75. PMID 28110677 DOI: 10.1016/J.Brat.2016.07.006  0.592
2016 Thakur ER, Quigley BM, El-Serag HB, Gudleski GD, Lackner JM. Medical comorbidity and distress in patients with irritable bowel syndrome: The moderating role of age. Journal of Psychosomatic Research. 88: 48-53. PMID 27521653 DOI: 10.1016/J.Jpsychores.2016.07.006  0.614
2014 Lackner JM, Gudleski GD, Ma CX, Dewanwala A, Naliboff B. Fear of GI symptoms has an important impact on quality of life in patients with moderate-to-severe IBS. The American Journal of Gastroenterology. 109: 1815-23. PMID 25223577 DOI: 10.1038/Ajg.2014.241  0.697
2014 Lackner JM, Gudleski GD, Thakur ER, Stewart TJ, Iacobucci GJ, Spiegel BM. The impact of physical complaints, social environment, and psychological functioning on IBS patients' health perceptions: looking beyond GI symptom severity. The American Journal of Gastroenterology. 109: 224-33. PMID 24419481 DOI: 10.1038/Ajg.2013.410  0.738
2013 Ljótsson B, Andersson E, Lindfors P, Lackner JM, Grönberg K, Molin K, Norén J, Romberg K, Andersson E, Hursti T, Hesser H, Hedman E. Prediction of symptomatic improvement after exposure-based treatment for irritable bowel syndrome. Bmc Gastroenterology. 13: 160. PMID 24245807 DOI: 10.1186/1471-230X-13-160  0.452
2013 Lackner JM, Gudleski GD, Firth R, Keefer L, Brenner DM, Guy K, Simonetti C, Radziwon C, Quinton S, Krasner SS, Katz L, Garbarino G, Iacobucci GD, Sitrin MD. Negative aspects of close relationships are more strongly associated than supportive personal relationships with illness burden of irritable bowel syndrome. Journal of Psychosomatic Research. 74: 493-500. PMID 23731746 DOI: 10.1016/J.Jpsychores.2013.03.009  0.606
2013 Lackner JM, Gudleski GD, Dimuro J, Keefer L, Brenner DM. Psychosocial predictors of self-reported fatigue in patients with moderate to severe irritable bowel syndrome. Behaviour Research and Therapy. 51: 323-31. PMID 23578499 DOI: 10.1016/J.Brat.2013.03.001  0.707
2013 Lackner JM, Ma CX, Keefer L, Brenner DM, Gudleski GD, Satchidanand N, Firth R, Sitrin MD, Katz L, Krasner SS, Ballou SK, Naliboff BD, Mayer EA. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 11: 1147-57. PMID 23524278 DOI: 10.1016/J.Cgh.2013.03.011  0.671
2013 Lackner JM, Jaccard J, Baum C. Multidomain patient-reported outcomes of irritable bowel syndrome: exploring person-centered perspectives to better understand symptom severity scores. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 16: 97-103. PMID 23337220 DOI: 10.1016/J.Jval.2012.08.2207  0.395
2012 Lackner JM, Keefer L, Jaccard J, Firth R, Brenner D, Bratten J, Dunlap LJ, Ma C, Byroads M. The Irritable Bowel Syndrome Outcome Study (IBSOS): Rationale and design of a randomized, placebo-controlled trial with 12month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome Contemporary Clinical Trials. 33: 1293-1310. PMID 22846389 DOI: 10.1016/J.Cct.2012.07.013  0.459
2011 Lackner J, Jaccard J, Baum C, Smith A, Krasner S, Katz L, Firth R, Raby T, Powell C. Patient-reported outcomes for irritable bowel syndrome are associated with patients' severity ratings of gastrointestinal symptoms and psychological factors. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 9: 957-964.e1. PMID 21699821 DOI: 10.1016/J.Cgh.2011.06.014  0.452
2010 Lackner JM, Gudleski GD, Keefer L, Krasner SS, Powell C, Katz LA. Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 8: 426-32. PMID 20170751 DOI: 10.1016/J.Cgh.2010.02.007  0.713
2008 Lackner JM, Jaccard J, Krasner SS, Katz LA, Gudleski GD, Holroyd K. Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 6: 899-906. PMID 18524691 DOI: 10.1016/J.Cgh.2008.03.004  0.681
2007 Lackner JM, Jaccard J, Krasner SS, Katz LA, Gudleski GD, Blanchard EB. How does cognitive behavior therapy for irritable bowel syndrome work? A mediational analysis of a randomized clinical trial. Gastroenterology. 133: 433-44. PMID 17681164 DOI: 10.1053/J.Gastro.2007.05.014  0.721
2007 Blanchard EB, Lackner JM, Sanders K, Krasner S, Keefer L, Payne A, Gudleski GD, Katz L, Rowell D, Sykes M, Kuhn E, Gusmano R, Carosella AM, Firth R, Dulgar-Tulloch L. A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome. Behaviour Research and Therapy. 45: 633-48. PMID 16979581 DOI: 10.1016/J.Brat.2006.07.003  0.679
2006 Lackner JM, Gudleski GD, Zack MM, Katz LA, Powell C, Krasner S, Holmes E, Dorscheimer K. Measuring health-related quality of life in patients with irritable bowel syndrome: can less be more? Psychosomatic Medicine. 68: 312-20. PMID 16554399 DOI: 10.1097/01.Psy.0000204897.25745.7C  0.653
2006 Blanchard EB, Lackner JM, Gusmano R, Gudleski GD, Sanders K, Keefer L, Krasner S. Prediction of treatment outcome among patients with irritable bowel syndrome treated with group cognitive therapy. Behaviour Research and Therapy. 44: 317-37. PMID 16413495 DOI: 10.1016/J.Brat.2005.01.003  0.711
2006 Lackner JM, Lou Coad M, Mertz HR, Wack DS, Katz LA, Krasner SS, Firth R, Mahl TC, Lockwood AH. Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxiety. Behaviour Research and Therapy. 44: 621-38. PMID 16039604 DOI: 10.1016/J.Brat.2005.05.002  0.355
2004 Lackner JM, Gudleski GD, Blanchard EB. Beyond abuse: the association among parenting style, abdominal pain, and somatization in IBS patients. Behaviour Research and Therapy. 42: 41-56. PMID 14744522 DOI: 10.1016/S0005-7967(03)00069-X  0.6
2003 Shipherd JC, Beck JG, Hamblen JL, Lackner JM, Freeman JB. A preliminary examination of treatment for posttraumatic stress disorder in chronic pain patients: a case study. Journal of Traumatic Stress. 16: 451-7. PMID 14584629 DOI: 10.1023/A:1025754310462  0.303
Show low-probability matches.